The PGBD2 gene (NCBI Gene ID: 267002) encodes a protein with homology to transposases from the piggyBac superfamily . Key features include:
While recombinant PGBD2 has not been extensively characterized, insights from homologous proteins suggest potential uses:
Low Annotation: PGBD2 is classified as understudied, with limited functional data (Pharos score: 0.35) .
Technical Barriers: No published protocols for recombinant PGBD2 purification or activity assays.
Studies on the closely related PGBD5 provide a framework for understanding PGBD2:
Key research priorities include:
Functional Validation: Developing assays to test recombinant PGBD2’s DNA transposition activity.
Structural Studies: Resolving 3D structures to clarify catalytic residues and substrate binding.
Therapeutic Exploration: Investigating roles in somatic genome diversification or disease.
Method: Use excision assays with plasmid-based piggyBac transposons. Co-transfect cells with recombinant PGBD2 and a reporter plasmid (e.g., pTpB with GFP/antibiotic resistance). Perform PCR amplification of excised transposons and Sanger sequencing to confirm TTAA target site reconstitution .
Controls: Include piggyBac transposase (positive control) and a catalytically inactive mutant (negative control). Quantify colony formation under antibiotic selection to assess transposition efficiency .
Protocol:
Parameter | Recommendation |
---|---|
Expected MW | 68 kDa (isoform 1) |
Observed MW | May vary due to PTMs |
Blocking Buffer | 5% non-fat milk in TBST |
Troubleshooting steps:
Key domains:
Functional assay: Perform EMSA with fluorescently labeled ITRs to compare binding affinity between PGBD2 and piggyBac transposase .
Case study: Henssen et al. (2016) reported PGBD5-mediated transposition in cancer cells, but follow-up studies found no activity for PGBD2/PGBD5 .
Resolution strategy:
Factor | Impact on Activity |
---|---|
ITR truncation | ↑ Sensitivity |
Transposase dosage | ↓ Overproduction inhibition |
Host cell type | Varies (e.g., HEK293 vs. HT-1080) |
Approach: